One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Active Pharmaceutical Ingredients > Central Nervous System Drugs Product Name:Carbamazepine CAS No.:298-46-4 Standard:USP, EP Price(USD):Negotiable Company:ZF Polpharma S.A.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: yes
Payment Terms: L/C
Carbamazepine
Long experience in in-house commercial manufacturing
High manufacturing capacity
Improved technology to meet the highest quality standards (all single impurities below 0,06%)
3 production lines
Status
Commercial
Therapeutic cat.
Neurology
Polymorphic form
Form III
CAS No.
298-46-4
EU DMF readiness
CEP
KOREAN DMF
US DMF readiness
Drug description
Carbamazepine is an anticonvulsant. It works by decreasing nerve impulses that cause seizures and nerve pain, such as trigeminal neuralgia and diabetic neuropathy. Carbamazepine is also used to treat bipolar disorder. Carbamazepine may also be used for purposes not listed in this medication guide.
Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).
Audited Supplier
Pharma Sources Insight January 2025
